Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL; Department of Behavioral Sciences, Rush University Medical Center, Chicago, IL.
Ann Neurol. 2013 Sep;74(3):478-89. doi: 10.1002/ana.23964. Epub 2013 Jul 10.
The pathologic indices of Alzheimer disease, cerebrovascular disease, and Lewy body disease accumulate in the brains of older persons with and without dementia, but the extent to which they account for late life cognitive decline remains unknown. We tested the hypothesis that these pathologic indices account for the majority of late life cognitive decline.
A total of 856 deceased participants from 2 longitudinal clinical-pathologic studies, Rush Memory and Aging Project and Religious Orders Study, completed a mean of 7.5 annual evaluations, including 17 cognitive tests. Neuropathologic examinations provided quantitative measures of global Alzheimer pathology, amyloid load, tangle density, macroscopic infarcts, microinfarcts, and neocortical Lewy bodies. Random coefficient models were used to examine the linear relation of pathologic indices with global cognitive decline. In subsequent analyses, random change point models were used to examine the relation of the pathologic indices with the onset of terminal decline and rates of preterminal and terminal decline (ie, nonlinear decline).
Cognition declined a mean of about 0.11 U per year (estimate = -0.109, standard error [SE] = 0.004, p < 0.001), with significant individual differences in rates of decline; the variance estimate for the individual slopes was 0.013 (SE = 0.112, p < 0.001). In separate analyses, global Alzheimer pathology, amyloid, tangles, macroscopic infarcts, and neocortical Lewy bodies were associated with faster rates of decline and explained 22%, 6%, 34%, 2%, and 8% of the variation in decline, respectively. When analyzed simultaneously, the pathologic indices accounted for a total of 41% of the variation in decline, and the majority remained unexplained. Furthermore, in random change point models examining the influence of the pathologic indices on the onset of terminal decline and the preterminal and terminal components of the cognitive trajectory, the common pathologic indices accounted for less than a third of the variation in the onset of terminal decline and rates of preterminal and terminal decline.
The pathologic indices of the common causes of dementia are important determinants of cognitive decline in old age and account for a large proportion of the variation in late life cognitive decline. Surprisingly, however, much of the variation in cognitive decline remains unexplained, suggesting that other important determinants of cognitive decline remain to be identified. Identification of the mechanisms that contribute to the large unexplained proportion of cognitive decline is urgently needed to prevent late life cognitive decline.
阿尔茨海默病、脑血管病和路易体病的病理指标在有痴呆和无痴呆的老年人群中积累,但它们在多大程度上导致晚年认知能力下降尚不清楚。我们检验了这样一个假设,即这些病理指标可以解释大部分晚年认知能力下降。
共有 856 名来自 2 项纵向临床病理研究(Rush 记忆与衰老项目和宗教秩序研究)的已故参与者完成了平均 7.5 次年度评估,包括 17 项认知测试。神经病理学检查提供了全球阿尔茨海默病病理、淀粉样蛋白负荷、缠结密度、宏观梗死、微梗死和新皮质路易体的定量测量。随机系数模型用于检验病理指标与整体认知下降的线性关系。在随后的分析中,随机变化点模型用于检验病理指标与终末期下降的起始以及预终末期和终末期下降的关系(即非线性下降)。
认知能力平均每年下降约 0.11 个单位(估计值=-0.109,标准误差[SE]=0.004,p<0.001),下降率存在显著的个体差异;个体斜率的方差估计值为 0.013(SE=0.112,p<0.001)。在单独的分析中,全球阿尔茨海默病病理、淀粉样蛋白、缠结、宏观梗死和新皮质路易体与更快的下降率相关,并分别解释了下降的 22%、6%、34%、2%和 8%的变异。当同时进行分析时,病理指标共解释了下降总变异的 41%,但大部分仍未得到解释。此外,在随机变化点模型中,研究病理指标对终末期下降起始以及认知轨迹的预终末期和终末期成分的影响时,常见的病理指标仅解释了终末期下降起始和预终末期和终末期下降率变化的三分之一以下。
常见痴呆病因的病理指标是老年认知能力下降的重要决定因素,占晚年认知能力下降的很大比例。然而,令人惊讶的是,认知能力下降的大部分仍未得到解释,这表明仍有其他重要的认知能力下降决定因素有待确定。迫切需要确定导致认知能力下降大部分无法解释的机制,以预防晚年认知能力下降。